What should sponsors determine prior to initiating clinical trial activities?

Boost your GCP E6 (R3) exam readiness. Improve your understanding with engaging, insightful questions. Test yourself with hints and detailed explanations. Prepare effectively!

Multiple Choice

What should sponsors determine prior to initiating clinical trial activities?

Before starting a clinical trial, sponsors must clearly define who will be responsible for each trial-related activity and allocate those tasks accordingly. This ensures accountability, proper oversight, and regulatory compliance across all aspects of the study—from protocol implementation and data management to safety reporting and monitoring. When roles and responsibilities are defined upfront, the trial can be organized and resourced appropriately, communication lines are clear, and training can be targeted to the right people. Without this upfront allocation, activities may be performed inconsistently or overlooked, jeopardizing participant safety and data integrity. The other options—branding color schemes, advertising language, or personal preferences like coffee choices—do not influence the initiation of trial activities or compliance with good clinical practice.

Before starting a clinical trial, sponsors must clearly define who will be responsible for each trial-related activity and allocate those tasks accordingly. This ensures accountability, proper oversight, and regulatory compliance across all aspects of the study—from protocol implementation and data management to safety reporting and monitoring. When roles and responsibilities are defined upfront, the trial can be organized and resourced appropriately, communication lines are clear, and training can be targeted to the right people. Without this upfront allocation, activities may be performed inconsistently or overlooked, jeopardizing participant safety and data integrity. The other options—branding color schemes, advertising language, or personal preferences like coffee choices—do not influence the initiation of trial activities or compliance with good clinical practice.

More practice questions